SCHEMBL18946397

SCHEMBL18946397

C=CNc1c(O)ccc(C(O)CNCCCCCc2cccc(CCc3cccc(CCO)c3)c2)c1/C=C\C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 19/20 0.43
▸ ADRB2 P07550 17/20 0.43
▸ ADRB3 P13945 7/20 0.40
▸ DRD2 P14416 2/20 0.40
▸ ADRA1D P25100 2/20 0.40
▸ DRD3 P35462 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ CHRM5 P08912 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ DRD4 P21917 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ FPR3 P25089 1/20 0.40
▸ HTR1D P28221 1/20 0.40
▸ HTR1B P28222 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ GPR183 P32249 1/20 0.40
▸ HTR7 P34969 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20373416 0.69 ADRB2 (0.40) ADRB1ADRB2DRD2DRD3
SCHEMBL21573556 0.68 ADRB2 (0.41) ADRB1ADRB2ADRB3DRD2ADRA1D
SCHEMBL21573521 0.64 KDM4E (0.37) ADRB1ADRB2DRD2ADRA1DKDM4E
SCHEMBL11692156 0.63 ADRB1 (0.57) ADRB1ADRB2DRD2ADRA1D
SCHEMBL23223709 0.61 ADRB2 (0.39) ADRB1ADRB2ADRA2BADRA1A
SCHEMBL29751132 0.61 ADRB2 (0.70) ADRB1ADRB2ADRB3DRD2ADRA1D
SCHEMBL461364 0.61 ADRB2 (0.70) ADRB1ADRB2ADRB3DRD2ADRA1D
SCHEMBL14542375 0.61 ADRB2 (1.00) ADRB1ADRB2ADRB3DRD2ADRA1D
SCHEMBL14542639 0.60 ADRB2 (0.81) ADRB1ADRB2ADRB3DRD2ADRA1D
SCHEMBL10477717 0.60 ADRB2 (0.86) ADRB1ADRB2ADRB3DRD2ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017093208-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2017-06-08 — — WO disclosed
Send feedback